awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35231826-05122DC4-B5AC-4FB7-A506-AAE4509D89A2
Q35231826-05122DC4-B5AC-4FB7-A506-AAE4509D89A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-05122DC4-B5AC-4FB7-A506-AAE4509D89A2
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
P2860
Q35231826-05122DC4-B5AC-4FB7-A506-AAE4509D89A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-05122DC4-B5AC-4FB7-A506-AAE4509D89A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
966528fce6da87a67c64b3b0add2cb5df3955829
P2860
Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.